CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Authors:
  • JBJennifer R. Brown
    Jennifer R. Brown
  • PHPeter Hillmen
    Peter Hillmen
  • BEBarbara Eichhorst
    Barbara Eichhorst
  • NLNicole Lamanna
    Nicole Lamanna
  • SOSusan O'BRien
    Susan O'BRien
  • CTConstantine S. Tam
    Constantine S. Tam
  • LQLugui Qiu
    Lugui Qiu
  • MKMaciej Kazmierczak
    Maciej Kazmierczak
  • KZKeshu Zhou
    Keshu Zhou
  • MŠMartin Šimkovič
    Martin Šimkovič
  • JMJiri Mayer
    Jiri Mayer
  • AGAmanda Gillespie-Twardy
    Amanda Gillespie-Twardy

Abstract
No abstract available